Remdesivir study finally published – ... - Lung Conditions C...

Lung Conditions Community Forum

55,519 members66,257 posts

Remdesivir study finally published – an expert in critical care medicine gives us his verdict.

2greys profile image
6 Replies

The results of the ACTT-1 trial, which looked at the effectiveness of remdesivir as a treatment for COVID-19, have finally been published. So far the only drug that has been shown to reduce deaths from the disease has been dexamethasone, a steroid that suppresses the immune system through its anti-inflammatory effects. Steroids have a secondary effect on the disease – they don’t target the virus itself. Remdesivir, on the other hand, goes straight to the cause of the disease by inhibiting the virus.

The drug, which was developed by Gilead Sciences, was approved for use by the US Food and Drug Administration under an “emergency use authorisation” on May 1. It was recently used to treat President Donald Trump.

theconversation.com/remdesi...

Written by
2greys profile image
2greys
To view profiles and participate in discussions please or .
Read more about...
6 Replies
deni-123red_ profile image
deni-123red_

Well if it was used on the POTUS the drug must be ok. That’s progress I guess but is the drug available in the UK I wonder.

Soul01 profile image
Soul01 in reply to deni-123red_

As far as I know, the Royal Free were taking part because they had used it when treating Ebola patients so I think it should be available in the U.K. but under what criteria is anyone’s guess!

deni-123red_ profile image
deni-123red_ in reply to Soul01

That’s interesting and perhaps it’s not yet been cleared to be used here yet for Covid patients. Possibly it’s in short supply too.

Thanks for the information

HungryHufflepuff profile image
HungryHufflepuff in reply to deni-123red_

This from the article: Based on these positive findings, it would be tempting to conclude that all patients who have the disease should receive the drug, but since it costs around US$2,340 (£1,795) to treat one patient, and is likely to be in short supply in the UK for the foreseeable future, the question warrants a more considered analysis.

So I guess it is in short supply in the U.K. 🤔

deni-123red_ profile image
deni-123red_ in reply to HungryHufflepuff

Yes that is a very expensive drug and unlikely to be cleared by NICE. The number of Ebola patients versus COVID patients is nowhere near comparable.

Mavary profile image
Mavary

This is why I wonder if Donald Trump really did have Covid or was it a Electoral ploy?

You may also like...

inspiratory muscle training

my ‘lungs off’the past few months, as I finally found my disease trigger and have been able to stay...

When the drugs don’t work

courses and antibiotics and steroids, and much pleading, he was finally referred back to Respiratory

Shuffling back to paradise

Finally cracked had one of my magnificent hissy fits after being told l had been prescribed 2...

Organising pneumonia - how soon do the steroids kick in?

lung condition and was started on a reducing dose steroid regime 3 weeks ago and am yet to feel any...

Non TB Mycobacterial infection

how this will go taking these drugs for so long and the side effects although I know I need to do...